AstraZeneca's 5R framework for decision-making in the drug discovery and development process. Links to the pdf's for these papers may be found in the Readings and Resources page of Module 4. Theory is theory, but many organizations have put the 5R concepts espoused by AZ into practice. In the Discussion forum, please provide your thoughts on any (does not have to be all) of the following: What are the pros and cons of their framework? Is there anything obvious that they left out? What if every company from start-up biotech to multi-national pharma adopted this approach as summarized